Han, B.; Liu, W.; Du, J.; Liu, H.; Zhao, T.; Yang, S.; Wang, S.; Zhang, S.; Liu, B.; Liu, Y.;
et al. 12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial. Vaccines 2021, 9, 1407.
https://doi.org/10.3390/vaccines9121407
AMA Style
Han B, Liu W, Du J, Liu H, Zhao T, Yang S, Wang S, Zhang S, Liu B, Liu Y,
et al. 12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial. Vaccines. 2021; 9(12):1407.
https://doi.org/10.3390/vaccines9121407
Chicago/Turabian Style
Han, Bingfeng, Wu Liu, Juan Du, Hanyu Liu, Tianshuo Zhao, Shubo Yang, Shuai Wang, Sihui Zhang, Bei Liu, Yaqiong Liu,
and et al. 2021. "12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial" Vaccines 9, no. 12: 1407.
https://doi.org/10.3390/vaccines9121407
APA Style
Han, B., Liu, W., Du, J., Liu, H., Zhao, T., Yang, S., Wang, S., Zhang, S., Liu, B., Liu, Y., & Cui, F.
(2021). 12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial. Vaccines, 9(12), 1407.
https://doi.org/10.3390/vaccines9121407
